Establishment Labs Holdings Inc 8-K, filed Dec 14, 2023
Establishment Labs Holdings Inc. (ESTA)
8-K
2023-12-14
For: 2023-12-08
View Original
Added on
April 08, 2026
About this 8-K
Establishment Labs Holdings Inc filed this 8-K on December 14, 2023, reporting on events of December 8, 2023.
Items reported
- Item 5.02: Director or officer change, or executive pay
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
| Date of Report (date of earliest event reported) | ||
(Exact name of registrant as specified in its charter)
| Not applicable | ||||||||||||||||||||
| (State or other jurisdiction of incorporation or organization) | (Commission File No.) | (I.R.S. Employer Identification Number) | ||||||||||||||||||
| Buiding B15 and 25 Coyol Free Zone Alajuela Costa Rica | ||||||||||||||||||||
| (Address of principal executive offices) (Zip Code) | ||||||||||||||||||||
| +506 2434 2400 | ||||||||||||||||||||
| (Registrant’s telephone number, including area code) | ||||||||||||||||||||
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading symbol | Name of each exchange on which registered | ||||||
| The NASDAQ Capital Market | ||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2) of this chapter.
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On December 8, 2023, Paul D. Rodio, the Company’s Chief Operating Officer, departed from Establishment Labs Holdings Inc. (the “Company”). In accordance with his employment agreement, a form of which was previously filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on December 2, 2022, contingent upon Mr. Rodio’s execution of a general release agreement, Mr. Rodio will be entitled to the severance benefits specified therein. Upon Mr. Rodio’s departure, Juan José Chacón Quirós, the Company's Chief Executive Officer, assumed the management responsibilities formerly held by Mr. Rodio as the Company’s principal operating officer, and Mr. Chacón Quirós will continue to have such management responsibilities until such time as the Company assigns them to another individual. Biographical and other information regarding Mr. Chacón Quirós, including his business experience and arrangements with the Company, are included under “Proposal 1: Election of Directors” and “Certain Relationships and Related Party Transactions” in the Company’s Definitive Proxy Statement on Schedule 14A filed with the SEC on April 12, 2023, which information is incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
ESTABLISHMENT LABS HOLDINGS INC. | ||||||||||||||
Dated: | December 14, 2022 | By: | /s/ Juan José Chacón Quirós | |||||||||||
Name: | Juan José Chacón Quirós | |||||||||||||
Title: | Chief Executive Officer | |||||||||||||